- Home
- KRUS vs RLAY Comparison
KRUS vs RLAY Comparison
Compare KRUS & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRUS
- RLAY
- Stock Information
- Founded
- KRUS 2008
- RLAY 2015
- Country
- KRUS United States
- RLAY United States
- Employees
- KRUS N/A
- RLAY N/A
- Industry
- KRUS Restaurants
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRUS Consumer Discretionary
- RLAY Health Care
- Exchange
- KRUS Nasdaq
- RLAY Nasdaq
- Market Cap
- KRUS 1.1B
- RLAY 619.0M
- IPO Year
- KRUS 2019
- RLAY 2020
- Fundamental
- Price
- KRUS $76.18
- RLAY $4.09
- Analyst Decision
- KRUS Buy
- RLAY Strong Buy
- Analyst Count
- KRUS 9
- RLAY 13
- Target Price
- KRUS $94.56
- RLAY $18.00
- AVG Volume (30 Days)
- KRUS 214.1K
- RLAY 1.2M
- Earning Date
- KRUS 11-05-2025
- RLAY 11-05-2025
- Dividend Yield
- KRUS N/A
- RLAY N/A
- EPS Growth
- KRUS N/A
- RLAY N/A
- EPS
- KRUS N/A
- RLAY N/A
- Revenue
- KRUS $269,327,000.00
- RLAY $8,355,000.00
- Revenue This Year
- KRUS $20.51
- RLAY $31.55
- Revenue Next Year
- KRUS $20.27
- RLAY N/A
- P/E Ratio
- KRUS N/A
- RLAY N/A
- Revenue Growth
- KRUS 18.76
- RLAY N/A
- 52 Week Low
- KRUS $40.03
- RLAY $1.78
- 52 Week High
- KRUS $110.66
- RLAY $8.19
- Technical
- Relative Strength Index (RSI)
- KRUS 39.68
- RLAY 60.92
- Support Level
- KRUS $78.07
- RLAY $3.89
- Resistance Level
- KRUS $82.21
- RLAY $4.34
- Average True Range (ATR)
- KRUS 3.92
- RLAY 0.24
- MACD
- KRUS -0.55
- RLAY 0.02
- Stochastic Oscillator
- KRUS 5.44
- RLAY 69.94
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).